
Samsung Bioepis and EpisNexLab partner with G2GBio to develop long-acting obesity treatments using microsphere-based drug delivery technology, while Samsung Epis Holdings invests 20 billion won in convertible bonds as part of open innovation strategy to expand into comprehensive bio company.
💉 GLP-1 Agonists - Feb 2026
• GLP-1RAs reduce heart failure risk vs DPP-4 inhibitors
• GLP-1RAs linked to optic neuropathy risk in younger patients
• Semaglutide shows chondroprotective effects in osteoarthritis
• Tirzepatide cuts major cardiovascular events vs placebo
• Income barriers affect semaglutide prescription uptake
• Semaglutide improves post-ablation outcomes in atrial fibrillation
💉 GLP-1RAs are now famous for their weight loss capabilities, but a new review suggests that the rebound weight people gain after stopping the medication is real, though you might not regain all of the weight back
#science #sciencenews #research #stem #facts #knowledge #sciencefacts #GLP1 #ozempic #wegovy #semaglutide #tirzepatide
💉 An international team of researchers say #GLP-1 RAs - the type of diabetes/weight loss drugs that include #Ozempic and #Wegovy - are more effective in women than men
https://www.scimex.org/newsfeed/ozempic-like-drugs-work-best-in-women
#science #sciencenews #research #stem #facts #knowledge #sciencefacts #semaglutide